查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1828123

2025年血红素检测全球市场报告

Hemoglobin Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，血红素检测市场规模强劲成长，从2024年的26.4亿美元增加至2025年的27.9亿美元，复合年增长率为5.6%。预测期内的成长归因于贫血盛行率的上升、孕产妇保健计画、捐血计画、慢性病管理以及全球健康意识提升宣传活动。

预计未来几年血红素检测市场规模将强劲成长，到2029年将达到39.1亿美元，复合年增长率为8.8%。预测期内的成长归因于医疗保健投资的增加、与慢性病管理的整合、就地检验的扩展、对预防保健的重视程度的提高以及全球卫生大流行病的防范。预测期内的主要趋势包括远端医疗和远端监控、技术进步、家用检测套组、与电子健康记录(EHR) 的整合以及对无创技术的关注。

血红蛋白检测是一种测量血液中血红素浓度的医疗程序。血红蛋白是红血球中的一种蛋白质，在将氧气从肺部输送到身体组织和器官的过程中发挥着至关重要的作用。

血红蛋白检测的主要产品类型包括试剂和耗材以及仪器。血红素检测市场的试剂和耗材部分包括血红素检测过程中使用的各种化学试剂和耗材。血红素检测采用各种技术，例如层析法、免疫测量和光强度。这些检测产品应用于各种环境，包括医院、诊所、实验室、居家医疗和血库。

2025年春季，美国关税突然上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战进一步加剧了形势，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供血红蛋白检测市场统计数据，例如全球血红蛋白检测行业规模、各地区市场份额、竞争对手的市场份额、详细的血红蛋白检测细分市场、市场趋势和机会，以及您在血红蛋白检测行业取得成功所需的数据。本血红蛋白检测市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年8.8%的预测成长率，较我们先前对该市场的预测略有下降0.1%。下降主要源自于美国与其他国家之间关税的影响。美国可能会直接感受到这种影响，因为来自墨西哥和丹麦等主要地区的非侵入式脉搏血氧饱和度感测器和微流体检测试剂盒的供应链中断，这可能导致血氧读数降低和紧急医疗费用增加。由于互惠关税以及贸易紧张局势和限制措施升级对全球经济和贸易的负面影响，这种影响也可能波及更广泛的地区。

随着糖尿病等慢性疾病的日益流行，血红素检测市场可望持续成长。糖尿病是一种以胰岛素生成和利用不足为特征的慢性疾病，需要定期进行糖化血红蛋白 (HbA1c) 检测。这些检测由美国糖尿病协会 ( 美国 Diabetes Association) 推荐，在糖尿病诊断中发挥关键作用。目前，超过 3,400 万美国人患有糖尿病，另有 8,800 万人面临患病风险，因此对 HbA1c 检测设备的需求只会持续增长。此外，全球预测显示，糖尿病患者数量将大幅增加，到 2045 年将达到 783,700 人，凸显了糖化血红蛋白检测设备在慢性疾病管理中的关键作用。

贫血盛行率的上升预计将在未来几年推动血红蛋白检测市场的成长。贫血是一种表现为红血球缺乏或血红素含量减少的疾病。血红蛋白是红血球中负责将氧气输送到身体组织的蛋白质。贫血盛行率的上升推动了对血红蛋白检测的需求，这是由于人们对早期发现和定期检测的需求日益增长，人们的认知度不断提高，对预防性医疗保健的重视以及贫血相关疾病的增多。这些因素共同推动了市场的显着成长，因为诊断服务对于大规模识别和管理贫血至关重要。例如，华盛顿大学医学院独立研究中心健康指标与评估研究所于2023年7月发布的报告估计，全球约四分之一的人口患有贫血，其中女性、孕妇、女孩和五岁以下儿童的贫血盛行率显着增加。因此，贫血盛行率的上升正在推动血红蛋白检测市场的成长。

预计不断增长的医疗保健支出将推动血红蛋白检测市场的未来成长。医疗保健支出是指特定地区、国家或经济体在特定期间内拨给医疗保健部门的公共和私人资金总额。不断增长的医疗保健支出将透过支援先进的诊断技术、扩大检测管道以及推广用于贫血检测和管理的综合筛检倡议来促进血红蛋白检测的发展。例如，英国国家统计局报告称，2022年至2023年，医疗保健总支出名义上将增加5.6%，而2022年的增幅仅为0.9%。因此，不断增长的医疗保健支出是血红蛋白检测市场的主要驱动力。

血红蛋白检测市场的主要企业正在开发创新的指尖采血检测解决方案，使患者能够在家中方便地监测血红蛋白水平，支持贫血的早期发现，并加强整体健康管理。这些先进的指尖采血检测方法只需简单的指尖采血即可快速轻鬆地采集血样，使诊断检测更有效率、更侵入性更小。例如，2024 年 2 月，美国健康科技公司 Sanguina Inc. 推出了 AnemoCheck Home，这是第一个获得 FDA 批准的家用血红蛋白检测套组。 AnemoCheck Home 旨在透过简单的指尖采血提供准确的血红蛋白测量。这款使用者友善的试剂套件包含所有必要的组件，包括测试设备和清晰的说明，无需前往实验室即可进行测试。 AnemoCheck Home 不仅使患者能够定期监测血红素水平，还可以促进贫血等潜在健康问题的早期发现。

血红蛋白检测市场的主要企业正在推出创新解决方案，例如本土快速血红蛋白检测试剂盒，以便快速准确地评估血红蛋白水平，提高偏远地区患者的可及性，并及时诊断和管理贫血等疾病。这些本土快速血红素检测套组检测套组检测套组SenzHb。 SenzHb 是一种尖端诊断工具，可透过简单、使用者友好的介面快速且准确地测量血红素水平。这种创新试剂套件只需抽取少量血液，适用于各种环境，包括农村和服务不足地区。

血红素检测市场的主要企业包括雅培实验室公司、拜耳医疗保健公司、丹纳赫公司、赛默飞世尔科技公司、罗氏公司、Bio-Rad Laboratories Inc.、第一三共株式会社、ACON Laboratories Inc.、DiaSys Diagnostic Systems GmbH、EKF Diagnostics Holdings PLC、E.Enoscnosr. Inc.、贝克曼库尔特诊断有限公司、Diazyme Laboratories Inc.、Radiometer A/S、Sysmex Corporation、BioMedomics Inc.、Hemosure Inc.、Humasis Co. Ltd.、Immunostics Inc.、LifeSign LLC、Medix Biochemica Oy AB、NanoenTek Inc. Corp.、西门子医疗有限公司、迈瑞医疗国际有限公司、日本光电株式会社和东曹株式会社。

2024年，亚太地区和北美是血红素检测市场最大的地区。预计亚太地区将成为预测期内全球血红素检测市场成长最快的地区。血红素检测市场报告涵盖亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

血红素检测市场报告涵盖的国家：澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利、西班牙

血红蛋白检测市场涵盖提供氰化血红蛋白、Vanzetti 迭氮化物高铁血红蛋白、无试剂非侵入性方法以及血红蛋白电泳等服务的营业单位所获得的收益。市场规模包括服务提供者销售或包含在服务产品中的相关商品的价值。它仅包括企业之间交易或销售给最终消费者的商品和服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球血红素检测：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球血红素检测市场：成长率分析
  • 全球血红素检测市场表现：规模与成长，2019-2024
  • 全球血红素检测市场预测：规模与成长，2024-2029年，2034年
  • 全球血红素检测：总潜在市场（TAM）

第六章 市场细分

  • 全球血红素检测市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 试剂和耗材
  • 装置
  • 全球血红素检测市场（依技术、效能和预测），2019-2024 年、2024-2029 年、2034 年
  • 层析法
  • 免疫检测
  • 光强度
  • 其他的
  • 全球血红素检测市场（按最终用户、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊所
  • 实验室
  • 居家照护
  • 血库
  • 其他的
  • 全球血红素检测市场：试剂和耗材细分、按类型、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 血红素检测套组
  • 控制解决方案
  • 测试条
  • 品管产品
  • 全球血红素检测市场：仪器细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 血红素仪
  • 分析器
  • 照护现场设备
  • 实验设备

第七章 区域和国家分析

  • 全球血红素检测市场：按地区、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 全球血红素检测市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 血红素检测市场：竞争格局
  • 血红素检测市场：公司简介
    • Abbott Laboratories Inc.
    • Bayer Medical Care Inc.
    • Danaher Corporation
    • Thermo Fisher Scientific Inc.
    • F. Hoffmann-La Roche AG

第31章：其他领先和创新企业

  • Bio-Rad Laboratories Inc.
  • Daiichi Sankyo Inc.
  • ACON Laboratories Inc.
  • DiaSys Diagnostic Systems GmbH
  • EKF Diagnostics Holdings PLC
  • Epinex Diagnostics Inc.
  • Erba Diagnostics Inc.
  • ARKRAY Inc.
  • Beckman Coulter Diagnostics Ltd.
  • Diazyme Laboratories Inc.
  • Radiometer A/S
  • Sysmex Corporation
  • BioMedomics Inc.
  • Hemosure Inc.
  • Humasis Co. Ltd.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029 年血红素检测市场：提供新机会的国家
  • 2029 年血红素检测市场：细分市场带来新机会
  • 2029年血红素检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r24193u

Hemoglobin testing is a medical procedure designed to measure the concentration of hemoglobin in the blood. Hemoglobin, a protein found in red blood cells, plays a crucial role in transporting oxygen from the lungs to the tissues and organs of the body.

The primary types of products in hemoglobin testing include reagents and consumables, as well as equipment. The reagents and consumables segment in the hemoglobin testing market encompasses various chemical reagents and consumable products utilized in the process of hemoglobin testing. Various technologies are employed for hemoglobin testing, including chromatography, immunoassay, spectrophotometry, and others. These testing products find application in diverse settings such as hospitals, clinics, laboratories, home care settings, blood banks, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The hemoglobin testing market research report is one of a series of new reports from The Business Research Company that provides hemoglobin testing market statistics, including hemoglobin testing industry global market size, regional shares, competitors with a hemoglobin testing market share, detailed hemoglobin testing market segments, market trends and opportunities, and any further data you may need to thrive in the hemoglobin testing industry. This hemoglobin testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hemoglobin testing market size has grown strongly in recent years. It will grow from $2.64 billion in 2024 to $2.79 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to the prevalence of anemia, maternal health initiatives, blood donation programs, chronic disease management, and global health awareness campaigns.

The hemoglobin testing market size is expected to see strong growth in the next few years. It will grow to $3.91 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to rising healthcare investments, integration with chronic disease management, point-of-care testing expansion, increasing focus on preventive healthcare, and global health pandemic preparedness. Major trends in the forecast period include telemedicine and remote monitoring, technological advancements, home-based testing kits, integration with electronic health records (EHR), and a focus on non-invasive methods.

The forecast of 8.8% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for non-invasive pulse CO-oximetry sensors and microfluidic testing cartridges, sourced from key regions such as Mexico and Denmark, which could lead to compromised blood oxygen measurements and increased emergency medicine expenses.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The hemoglobin testing market is poised for growth, driven by the increasing prevalence of chronic disorders such as diabetes. Diabetes, a chronic condition characterized by insufficient insulin production or utilization, necessitates regular monitoring through Hemoglobin A1c tests (HbA1c). These tests, recommended by the American Diabetes Association, play a crucial role in diabetes diagnosis. With over 34 million Americans having diabetes and an additional 88 million at risk, the demand for HbA1c testing devices is set to rise. Furthermore, global projections indicate a substantial increase in diabetes cases, reaching 783,700 individuals by 2045, emphasizing the pivotal role of hemoglobin A1c testing devices in managing chronic disorders.

The increasing incidence of anemia is expected to enhance the growth of the hemoglobin testing market in the future. Anemia is a medical condition marked by a shortage of red blood cells or a reduction in the amount of hemoglobin, a protein in red blood cells responsible for transporting oxygen to body tissues. The rising prevalence of anemia fuels the demand for hemoglobin testing, driven by a heightened need for early detection, routine testing, greater awareness, a focus on preventive healthcare, and an increase in anemia-related conditions. These factors collectively contribute to the market's significant growth, as diagnostic services are crucial in identifying and managing anemia on a larger scale. For example, a report published in July 2023 by the Institute for Health Metrics and Evaluation, an independent research center at the University of Washington School of Medicine, estimated that about one-fourth of the global population is anemic, with a notable increase in cases among women, pregnant women, young girls, and children under five. Therefore, the rising prevalence of anemia is driving the growth of the hemoglobin testing market.

The increasing healthcare expenditure is projected to drive the growth of the hemoglobin testing market in the future. Healthcare expenditure refers to the total funds, both public and private, allocated to the healthcare sector within a specific geographical area, country, or economy over a defined period. A rise in healthcare spending enhances hemoglobin testing by supporting advanced diagnostic technologies, increasing access to testing, and promoting comprehensive screening initiatives for the detection and management of anemia. For example, a report from the Office for National Statistics, a UK-based government department, revealed that total healthcare expenditure grew by 5.6% in nominal terms from 2022 to 2023, compared to a mere 0.9% increase in 2022. Thus, the growing healthcare expenditure is a key driver of the hemoglobin testing market.

Leading companies in the hemoglobin testing market are creating innovative fingerstick blood test solutions to enable patients to conveniently monitor their hemoglobin levels at home, support early detection of anemia, and enhance overall health management. These advanced fingerstick blood test methods allow for quick and easy blood sample collection through a simple finger prick, making diagnostic testing more efficient and less invasive. For example, in February 2024, Sanguina Inc., a health technology company based in the U.S., launched AnemoCheck Home, the first FDA-cleared home hemoglobin test kit. AnemoCheck Home is designed to provide users with accurate hemoglobin readings using a simple finger prick. This user-friendly kit includes all the necessary components, such as a testing device and clear instructions, enabling individuals to conduct the test without needing a laboratory visit. AnemoCheck Home not only allows patients to regularly monitor their hemoglobin levels but also promotes early detection of potential health issues like anemia.

Key companies in the hemoglobin testing market are introducing innovative solutions like indigenous rapid hemoglobin testing kits to deliver quick and accurate assessments of hemoglobin levels, improve accessibility for patients in remote areas, and enable timely diagnosis and management of conditions such as anemia. These indigenous rapid hemoglobin testing kits are locally developed diagnostic tools designed to efficiently measure hemoglobin levels in individuals. For instance, in June 2023, the Indian Institute of Toxicology Research (IITR), a research organization based in India, launched SenzHb, a rapid hemoglobin testing kit. SenzHb is a state-of-the-art diagnostic tool that enables fast and precise measurement of hemoglobin levels through a simple, user-friendly interface. This innovative kit requires only a small blood sample, making it suitable for use in various settings, including rural and underserved communities.

Major companies operating in the hemoglobin testing market include Abbott Laboratories Inc., Bayer Medical Care Inc., Danaher Corporation, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories Inc., Daiichi Sankyo Inc., ACON Laboratories Inc., DiaSys Diagnostic Systems GmbH, EKF Diagnostics Holdings PLC, Epinex Diagnostics Inc., Erba Diagnostics Inc., ARKRAY Inc., Beckman Coulter Diagnostics Ltd., Diazyme Laboratories Inc., Radiometer A/S, Sysmex Corporation, BioMedomics Inc., Hemosure Inc., Humasis Co. Ltd., Immunostics Inc., LifeSign LLC, Medix Biochemica Oy AB, NanoenTek Inc., Nova Biomedical Corp., Siemens Healthcare GmbH, Mindray Medical International Limited, Nihon Kohden Corporation, Tosoh Corporation

Asia-Pacific and North America were the largest region in the hemoglobin testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global hemoglobin testing market report during the forecast period. The regions covered in the hemoglobin testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hemoglobin testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hemoglobin testing market consists of revenues earned by entities by providing services such as hemoglobin-cyanide, vanzetti's azide methemoglobin, reagent-less, non-invasive methods, and hemoglobin electrophoresis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hemoglobin Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hemoglobin testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hemoglobin testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hemoglobin testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Reagents And Consumables; Equipment
  • 2) By Technology: Chromatography; Immunoassay; Spectrophotometry; Other Technologies
  • 3) By End User: Hospitals; Clinics; Laboratories; Home Care Settings; Blood Banks; Other End Users
  • Subsegments:
  • 1) By Reagents And Consumables: Hemoglobin Testing Kits; Control Solutions; Test Strips; Quality Control Products
  • 2) By Equipment: Hemoglobin Meters; Analyzers; Point-Of-Care Devices; Laboratory Equipment
  • Companies Mentioned: Abbott Laboratories Inc.; Bayer Medical Care Inc.; Danaher Corporation; Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche AG; Bio-Rad Laboratories Inc.; Daiichi Sankyo Inc.; ACON Laboratories Inc.; DiaSys Diagnostic Systems GmbH; EKF Diagnostics Holdings PLC; Epinex Diagnostics Inc.; Erba Diagnostics Inc.; ARKRAY Inc.; Beckman Coulter Diagnostics Ltd.; Diazyme Laboratories Inc.; Radiometer A/S; Sysmex Corporation; BioMedomics Inc.; Hemosure Inc.; Humasis Co. Ltd.; Immunostics Inc.; LifeSign LLC; Medix Biochemica Oy AB; NanoenTek Inc.; Nova Biomedical Corp.; Siemens Healthcare GmbH; Mindray Medical International Limited; Nihon Kohden Corporation; Tosoh Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hemoglobin Testing Market Characteristics

3. Hemoglobin Testing Market Trends And Strategies

4. Hemoglobin Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Hemoglobin Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Hemoglobin Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Hemoglobin Testing Market Growth Rate Analysis
  • 5.4. Global Hemoglobin Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Hemoglobin Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Hemoglobin Testing Total Addressable Market (TAM)

6. Hemoglobin Testing Market Segmentation

  • 6.1. Global Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents And Consumables
  • Equipment
  • 6.2. Global Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chromatography
  • Immunoassay
  • Spectrophotometry
  • Other Technologies
  • 6.3. Global Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Laboratories
  • Home Care Settings
  • Blood Banks
  • Other End Users
  • 6.4. Global Hemoglobin Testing Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hemoglobin Testing Kits
  • Control Solutions
  • Test Strips
  • Quality Control Products
  • 6.5. Global Hemoglobin Testing Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hemoglobin Meters
  • Analyzers
  • Point-Of-Care Devices
  • Laboratory Equipment

7. Hemoglobin Testing Market Regional And Country Analysis

  • 7.1. Global Hemoglobin Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Hemoglobin Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hemoglobin Testing Market

  • 8.1. Asia-Pacific Hemoglobin Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hemoglobin Testing Market

  • 9.1. China Hemoglobin Testing Market Overview
  • 9.2. China Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hemoglobin Testing Market

  • 10.1. India Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hemoglobin Testing Market

  • 11.1. Japan Hemoglobin Testing Market Overview
  • 11.2. Japan Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hemoglobin Testing Market

  • 12.1. Australia Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hemoglobin Testing Market

  • 13.1. Indonesia Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hemoglobin Testing Market

  • 14.1. South Korea Hemoglobin Testing Market Overview
  • 14.2. South Korea Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hemoglobin Testing Market

  • 15.1. Western Europe Hemoglobin Testing Market Overview
  • 15.2. Western Europe Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hemoglobin Testing Market

  • 16.1. UK Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hemoglobin Testing Market

  • 17.1. Germany Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hemoglobin Testing Market

  • 18.1. France Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hemoglobin Testing Market

  • 19.1. Italy Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hemoglobin Testing Market

  • 20.1. Spain Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hemoglobin Testing Market

  • 21.1. Eastern Europe Hemoglobin Testing Market Overview
  • 21.2. Eastern Europe Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hemoglobin Testing Market

  • 22.1. Russia Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hemoglobin Testing Market

  • 23.1. North America Hemoglobin Testing Market Overview
  • 23.2. North America Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hemoglobin Testing Market

  • 24.1. USA Hemoglobin Testing Market Overview
  • 24.2. USA Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hemoglobin Testing Market

  • 25.1. Canada Hemoglobin Testing Market Overview
  • 25.2. Canada Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hemoglobin Testing Market

  • 26.1. South America Hemoglobin Testing Market Overview
  • 26.2. South America Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hemoglobin Testing Market

  • 27.1. Brazil Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hemoglobin Testing Market

  • 28.1. Middle East Hemoglobin Testing Market Overview
  • 28.2. Middle East Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hemoglobin Testing Market

  • 29.1. Africa Hemoglobin Testing Market Overview
  • 29.2. Africa Hemoglobin Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Hemoglobin Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Hemoglobin Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hemoglobin Testing Market Competitive Landscape And Company Profiles

  • 30.1. Hemoglobin Testing Market Competitive Landscape
  • 30.2. Hemoglobin Testing Market Company Profiles
    • 30.2.1. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Bayer Medical Care Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

31. Hemoglobin Testing Market Other Major And Innovative Companies

  • 31.1. Bio-Rad Laboratories Inc.
  • 31.2. Daiichi Sankyo Inc.
  • 31.3. ACON Laboratories Inc.
  • 31.4. DiaSys Diagnostic Systems GmbH
  • 31.5. EKF Diagnostics Holdings PLC
  • 31.6. Epinex Diagnostics Inc.
  • 31.7. Erba Diagnostics Inc.
  • 31.8. ARKRAY Inc.
  • 31.9. Beckman Coulter Diagnostics Ltd.
  • 31.10. Diazyme Laboratories Inc.
  • 31.11. Radiometer A/S
  • 31.12. Sysmex Corporation
  • 31.13. BioMedomics Inc.
  • 31.14. Hemosure Inc.
  • 31.15. Humasis Co. Ltd.

32. Global Hemoglobin Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hemoglobin Testing Market

34. Recent Developments In The Hemoglobin Testing Market

35. Hemoglobin Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Hemoglobin Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Hemoglobin Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Hemoglobin Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer